0.0(top 100%)
impact factor
112.8K(top 0.1%)
papers
749(top 50%)
citations
6(top 50%)
h-index
0.0(top 100%)
impact factor
246.9K
all documents
1.2K
doc citations
10(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Pfizer-BioNTech COVID-19 vaccine safe in childrenReactions Weekly202230
2Factor-VIII/von Willebrand factorReactions Weekly201527
3Nicardipine/tacrolimus interactionReactions Weekly201520
4Wasp-venom-allergy-immunotherapy/yellow-jacket-venomReactions Weekly201516
5The European Agency for the Evaluation of Medicinal Products (EMEA) patients' working group,Reactions Weekly200315
6Antiretrovirals/warfarin interactionReactions Weekly201811
7The EMA has released two more modules of its guideline on good pharmacovigilance practices (GVP).Reactions Weekly20128
8New warning of nusinersen-related communicating hydrocephalusReactions Weekly20188
9Warfarin/zingiber-officiales interactionReactions Weekly20198
10Dopamine receptor agonistsReactions Weekly20208
11Pfizer-BioNTech COVID-19 vaccine safe with clozapineReactions Weekly20228
12DPP-4 inhibitors may cause severe joint painReactions Weekly20157
13Safety of second Pfizer-BioNTech COVID-19 vaccine boosterReactions Weekly20227
14Omeprazole/warfarin interactionReactions Weekly20196
15TTS rare after AstraZeneca COVID-19 vaccineReactions Weekly20226
16Paradoxical findings in halted MOXCON trialReactions Weekly19995
17Human papillomavirus vaccineReactions Weekly20195
18MHRA Yellow Card reports on COVID-19 vaccine adverse reactionsReactions Weekly20215
19March 2021 PRAC meeting highlights include COVID-19 vaccine updateReactions Weekly20215
20Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccinesReactions Weekly20225
21The 'Erice Declaration' ??? communicating drug safety informationReactions Weekly19974
22Vinca alkaloidsReactions Weekly20074
23Second HPRA safety update on COVID-19 vaccinesReactions Weekly20214
24Histamine H1 receptor antagonistsReactions Weekly20133
25Traditional Chinese medicineReactions Weekly20133
26UMC investigates use of observational data to id ADRsReactions Weekly20133
27EMA good practice guide on medication errorsReactions Weekly20153
28Immune checkpoint inhibitors: fatal toxic effectsReactions Weekly20183
29VigiBase now contains around 17 million ADR reportsReactions Weekly20183
30FDA requests market withdrawal of all ranitidine productsReactions Weekly20203
31FDA requires labelling changes for drugs treating opioid overdoseReactions Weekly20203
32Global operation targets rise in counterfeit COVID-related medical itemsReactions Weekly20203
33Allopurinol/azathioprine interactionReactions Weekly20213
34FDA reports recall of Innova COVID-19 antigen rapid qualitative testReactions Weekly20213
35Pfizer recalls all lots of varenicline in USA due to nitrosamineReactions Weekly20213
36Myocarditis rare after COVID-19 mRNA vaccinationReactions Weekly20213
37Safety aspects of intravenous ciprofloxacin in clinical practiceReactions Weekly19952
38US FDA to waive non-serious adverse event reportingReactions Weekly19972
39EMEA recommends restricting nimesulide useReactions Weekly20072
40The Canadian Adverse Drug Reaction Monitoring Program has been renamed as Canada Vigilance.Reactions Weekly20082
41Fentanyl overdoseReactions Weekly20102
42US FDA 2009 drug safety warnings analysedReactions Weekly20122
43Filgrastim/methotrexateReactions Weekly20132
44WEB-RADR: new social media project for ADR monitoring in EUReactions Weekly20142
45Vantictumab and OMP-54F78 trials on hold to assess adverse eventsReactions Weekly20142
46PRAC recommends restricting use of bromocriptineReactions Weekly20142
47Escitalopram withdrawalReactions Weekly20142
48New EMA recommendations on TecfideraReactions Weekly20152
49Calcium polystyrene sulfonateReactions Weekly20152
50INTERPOL targets illicit sale of fake medicines, products onlineReactions Weekly20162